Compare BAOS & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAOS | ACON |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.0M |
| IPO Year | 2021 | 2022 |
| Metric | BAOS | ACON |
|---|---|---|
| Price | $2.70 | $2.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 34.8K | ★ 141.3K |
| Earning Date | 05-08-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $860,951.00 | $67,483.00 |
| Revenue This Year | N/A | $71.77 |
| Revenue Next Year | N/A | $80.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.20 | ★ 36.91 |
| 52 Week Low | $1.52 | $2.34 |
| 52 Week High | $8.30 | $229.50 |
| Indicator | BAOS | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 32.64 |
| Support Level | $2.60 | $2.50 |
| Resistance Level | $2.86 | $2.85 |
| Average True Range (ATR) | 0.23 | 0.25 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 14.29 | 16.90 |
Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.